[WIS 2024] SKIA OPD

SKIA Showcases AR-Based Patient Education Solution SKIA OPD at WIS 2024

SKIA (CEO Jongmyung Lee) unveiled its AR-based patient education solution SKIA OPD at WIS 2024, designed to help patients understand pathological conditions, surgical procedures, and recovery progress through augmented reality.

SKIA is a medical technology company that develops markerless AR solutions. Its platform is the first in the world to align medical images with the patient’s body without using physical markers. The solution has already undergone exploratory clinical trials for breast cancer, a soft tissue indication.

Traditional medical imaging techniques like CT scans are two-dimensional and often difficult to correlate accurately with a patient's three-dimensional anatomy. This can lead to confusion between left and right, and it’s often hard to identify the precise location of a particular image slice. Such issues can cause errors in surgical planning or execution, potentially leading to serious medical accidents, including operations on incorrect sites or increased patient harm.

SKIA OPD reconstructs these flat medical images into 3D and projects them in real time onto the patient's body using AR. It can accurately visualize the CT scan location along with internal organs, bones, lesions, and blood vessels. This helps reduce variations in surgical outcomes based on physician experience and creates a more reassuring environment for patients. It also enables doctors to explain diagnoses and procedures more clearly and intuitively to patients and their families during consultations and surgical planning.

SKIA’s solution meets the navigation stereotactic accuracy standards recommended by the U.S. FDA. While conventional medical navigation systems allow an error margin of up to 2 mm, SKIA’s solution achieves an average error of 1.4 mm in the head and neck region and 1.7 mm in the upper body.

The company is now integrating AI technology into its solution to automatically segment target areas such as skin, blood vessels, organs, and lesions. This allows precise 3D alignment without invasive, marker-based methods that could harm the patient.

To support its expansion into the Indian market, SKIA has established a joint venture, SKIA India LLP, with local experts. The company is conducting a pilot program for outpatient education using its solution at a major hospital in Hyderabad.

Electronic Times, Reporter Hye-young SongApril 16, 2024

Original article: https://www.etnews.com/20240411000073